This article comprehensively explores the intricate interplay between neurotransmitters, emotions, and investment outcomes. Focusing on dopamine, serotonin, and norepinephrine, it uncovers the neural processes underpinning investor behavior and decision-making, elucidating the role of these biochemical messengers in shaping emotional reactions to investment results. Referencing studies in investor education and financial management, the article delves into neural mechanisms driving decision diversification, highlighting the influence of neurotransmitters like dopamine, serotonin, and norepinephrine on investment choices. It also addresses biases stemming from emotional, cognitive, and behavioral factors, underscoring the importance of education in cognitive function and bias mitigation. In its entirety, this compilation sheds light on the intricate influence of neurotransmitters, offering valuable insights into the complexities of investor behavior and its effective management within the realm of finance.